CohBar Inc.

1.14+0.0100+0.88%Vol 439.34K1Y Perf -23.74%
Apr 19th, 2021 16:00 DELAYED
BID1.14 ASK1.19
Open1.16 Previous Close1.13
Pre-Market- After-Market-
 - -  - -%
Target Price
6.40 
Analyst Rating
Strong Buy 1.00
Potential %
461.40 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/60/45 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-100/-100/-72 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/90/86 
Income Ranking
 —    -
Market Cap70.44M 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
8.53 
Earnings Date
13th May 2021

Today's Price Range

1.081.18

52W Range

0.85004.25

5 Year PE Ratio Range

-10.20-11.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-6.56%
1 Month
-23.49%
3 Months
-24.00%
6 Months
19.25%
1 Year
-23.74%
3 Years
-74.32%
5 Years
-43.00%
10 Years
-

TickerPriceChg.Chg.%
CWBR1.140.01000.88
AAPL134.840.68000.51
GOOG2 302.404.64000.20
MSFT258.74-2.0000-0.77
XOM56.48-0.1800-0.32
WFC43.880.04000.09
JNJ162.690.45000.28
FB302.24-3.9400-1.29
GE13.460.07000.52
JPM152.65-0.6500-0.42
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.06-0.08-33.33
Q03 2020-0.05-0.0420.00
Q02 2020-0.06-0.09-50.00
Q01 2020--0.06-
Q04 2019--0.09-
Q03 2019--0.08-
Q02 2019--0.07-
Q01 2019--0.07-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.06-20.00Negative
6/2021 QR-0.06-20.00Negative
12/2021 FY-0.32-10.34Negative
12/2022 FY-0.5529.49Positive
Next Report Date13th May 2021
Estimated EPS Next Report-0.06
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume439.34K
Shares Outstanding61.79M
Trades Count1.41K
Dollar Volume885.92K
Avg. Volume682.87K
Avg. Weekly Volume500.81K
Avg. Monthly Volume464.87K
Avg. Quarterly Volume749.34K

CohBar Inc. (NASDAQ: CWBR) stock closed at 1.14 per share at the end of the most recent trading day (a 0.88% change compared to the prior day closing price) with a volume of 439.56K shares and market capitalization of 70.44M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 13 people. CohBar Inc. CEO is Steven B. Engle.

The one-year performance of CohBar Inc. stock is -23.74%, while year-to-date (YTD) performance is -14.93%. CWBR stock has a five-year performance of -43%. Its 52-week range is between 0.85 and 4.25, which gives CWBR stock a 52-week price range ratio of 8.53%

CohBar Inc. currently has a PE ratio of -3.40, a price-to-book (PB) ratio of 3.78, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -91.79%, a ROC of -78.74% and a ROE of -122.18%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from CohBar Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.06 for the next earnings report. CohBar Inc.’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for CohBar Inc. is Strong Buy (1), with a target price of $6.4, which is +461.40% compared to the current price. The earnings rating for CohBar Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CohBar Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CohBar Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 19.96, ATR14 : 0.14, CCI20 : -160.44, Chaikin Money Flow : -0.29, MACD : -0.14, Money Flow Index : 37.40, ROC : -16.18, RSI : 32.00, STOCH (14,3) : 14.29, STOCH RSI : 0.09, UO : 33.56, Williams %R : -85.71), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CohBar Inc. in the last 12-months were: Albion J. Fitzgerald (Buy at a value of $0), David L. Greenwood (Buy at a value of $0), Jeffrey F. Biunno (Buy at a value of $0), Jon Stern (Buy at a value of $0), Kenneth C. Cundy (Option Excercise at a value of $36 500), Kenneth C. Cundy (Sold 50 000 shares of value $106 700 ), Misha Petkevich (Buy at a value of $17 220)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
0
0
Moderate Buy
0 (0.00 %)
0
0
Hold
0 (0.00 %)
0
0
Moderate Sell
0 (0.00 %)
0
0
Strong Sell
0 (0.00 %)
0
0
Summary RatingStrong Buy
1.00
--

CohBar Inc.

CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drug such as CB4209 and CB4211, SHLP-6, SHLP-2 and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operation of the group is functioned through the region of United States.

CEO: Steven B. Engle

Telephone: +1 650 446-7888

Address: 1455 Adams Drive, Menlo Park 94025, CA, US

Number of employees: 13

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

54%46%

Bearish Bullish

51%49%

News

Stocktwits